Megan Schutt Handed Two-Match Ban for Prescription Medication Breach
Australia have been dealt a surprise blow on the eve of a series decider. Veteran fast bowler Megan Schutt has been suspended for two matches by Cricket Australia for failing to comply with the board's Sports Science and Sports Medicine guidelines on the use of prescription medication.
The 33-year-old will miss Thursday's third and final T20I against New Zealand at North Sydney Oval — with Australia leading the series 2-0 and chasing a sweep — as well as Adelaide Strikers' WBBL opener against Melbourne Stars on October 31. The ban covers all international and domestic cricket.
• A single, one-off incident during an out-of-competition period, before the series against Bangladesh.
• The medication was not performance-enhancing — Cricket Australia stressed this explicitly.
• Schutt accepted the penalty immediately and apologised.
• CA says it will "continue to provide appropriate support to Megan."
Schutt Accepts the Penalty
Cricket Australia's statement on Thursday was unambiguous: "The breach was a failure to adhere to requirements under the Sports Science and Sports Medicine guidelines with regard to prescription medication. This relates to a single incidence which occurred while out of competition and was not for performance enhancing purposes."
Schutt, who has played 114 ODIs and 126 T20Is for Australia and was a standout in the recent one-day series against Bangladesh, released her own statement accepting the sanction: "I fully accept the penalty handed down and apologise for failing to meet the standards expected of me. I'm sorry for the attention this has caused and appreciate the support I've received."
"While this occurred out of competition and was not performance related," she added, "I understand that I am responsible for following the Sports Science and Sports Medicine Guidelines, which players receive regular education on, and I should have adhered to these guidelines."
A Timely Blow for Australia
The timing could hardly be worse. Australia's women are in the middle of a home summer that also includes the ongoing tri-nation women's ODI series context and the WBBL build-up, and Schutt remains one of the most reliable new-ball operators in the women's game. Her absence hands New Zealand a genuine opening in the series finale at North Sydney Oval — and forces the Strikers to reshuffle their new-ball plans for the WBBL curtain-raiser.
The episode is a reminder of how seriously elite boards now treat even off-field medication protocols: one lapse, no performance benefit, and a two-match ban all the same.